ZA201002260B - Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord - Google Patents

Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord

Info

Publication number
ZA201002260B
ZA201002260B ZA2010/02260A ZA201002260A ZA201002260B ZA 201002260 B ZA201002260 B ZA 201002260B ZA 2010/02260 A ZA2010/02260 A ZA 2010/02260A ZA 201002260 A ZA201002260 A ZA 201002260A ZA 201002260 B ZA201002260 B ZA 201002260B
Authority
ZA
South Africa
Prior art keywords
optimised
preservation
isolation
umbilical cord
precursor cells
Prior art date
Application number
ZA2010/02260A
Other languages
English (en)
Inventor
Monteiro Da Cruz Pedro Estilita
Vera Alexandra Basto
Jose Paulo Martins
Da Cruz Helder Joaquim Soares
Santos Jorge Miguel Silva
Coelho Maria Constanca Baptista
Soares Rita Isabel Ganchas
Original Assignee
Laboratorio Medinfar-Produtos Farm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Medinfar-Produtos Farm Sa filed Critical Laboratorio Medinfar-Produtos Farm Sa
Publication of ZA201002260B publication Critical patent/ZA201002260B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
ZA2010/02260A 2007-10-04 2010-03-30 Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord ZA201002260B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT103843A PT103843B (pt) 2007-10-04 2007-10-04 Método de isolamento de células precursoras a partir do cordão umbilical humano
PCT/IB2008/054067 WO2009044379A2 (en) 2007-10-04 2008-10-03 Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord

Publications (1)

Publication Number Publication Date
ZA201002260B true ZA201002260B (en) 2011-06-29

Family

ID=40456372

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/02260A ZA201002260B (en) 2007-10-04 2010-03-30 Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord

Country Status (15)

Country Link
US (1) US9546353B2 (enExample)
EP (1) EP2203555B1 (enExample)
JP (1) JP5785394B2 (enExample)
KR (1) KR20100087705A (enExample)
CN (1) CN101868536B (enExample)
AU (1) AU2008306442B2 (enExample)
BR (1) BRPI0817522A2 (enExample)
CA (1) CA2701907A1 (enExample)
EA (1) EA025532B1 (enExample)
ES (1) ES2582369T3 (enExample)
IL (1) IL204788A (enExample)
MX (1) MX2010003511A (enExample)
PT (1) PT103843B (enExample)
WO (1) WO2009044379A2 (enExample)
ZA (1) ZA201002260B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2634545T3 (es) 2010-06-01 2017-09-28 Auxocell Laboratories, Inc. Células madre nativas de la gelatina de Wharton y su purificación
US9234177B2 (en) 2010-10-18 2016-01-12 Sunshine Life Science & Technology Corp. Human multipotent embryonic stem cell-like progenitor cells
TWI535377B (zh) * 2011-09-01 2016-06-01 Storage, culture and application of umbilical cord tissue and its derived cells
ES2890126T3 (es) * 2011-12-30 2022-01-17 Amit Patel Métodos y composiciones para la obtención clínica de una célula alogénica y usos terapéuticos
CN102550543B (zh) * 2012-02-10 2014-04-16 四川新生命干细胞科技股份有限公司 用于保存脐带组织的液体
CN103461322B (zh) * 2012-06-07 2016-08-03 西比曼生物科技（上海）有限公司 用于冻存复苏后的细胞的保存液
EP2756754B1 (de) 2013-01-17 2017-01-04 Vita 34 Ag Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes
WO2015181831A2 (en) * 2014-05-24 2015-12-03 Venkataramanaa Neelamkrishnan A method for targettingglioblastoma with wharton jelly-mesenchymal stem cells (wj-msc) derived from human umbilical cord
JP2017533917A (ja) * 2014-11-05 2017-11-16 ティッシュテック，インク． 神経成長および再生を促進するための組成物および方法
WO2017004460A1 (en) * 2015-06-30 2017-01-05 Surgenex, LLC Compositions and methods for flowable allograft tissue
WO2017096611A1 (zh) * 2015-12-11 2017-06-15 郭镭 一种从脐带华通氏胶组织中分离培养脐带间充质干细胞的方法
WO2019175773A1 (en) 2018-03-12 2019-09-19 Universidade Do Porto Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells
CN112342191A (zh) * 2019-08-07 2021-02-09 路春光 hMSC生产试剂盒开发和质量管理标准优化和体系建立
CN111893092A (zh) * 2020-06-28 2020-11-06 国大生命科学产业集团(深圳)有限公司 一种人脐带来源的间充质干细胞及其制备方法
CN113025567A (zh) * 2021-03-31 2021-06-25 中国人民解放军陆军特色医学中心 一种椎间盘单细胞的分离方法
DE102021116694B4 (de) * 2021-06-29 2023-03-09 Promocell Gmbh Wässrige Lösung zur Zellkonservierung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402890B (de) * 1994-03-16 1997-09-25 Berbi Gmbh Verwendung von notoginsenosid r1 zur herstellung von arzneimitteln
JPWO2003080822A1 (ja) * 2002-03-27 2005-07-28 ニプロ株式会社 胎盤由来の間葉系細胞およびその医学的用途
CA2633980A1 (en) * 2005-12-29 2007-07-12 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
ES2524443T3 (es) * 2006-11-13 2014-12-09 DePuy Synthes Products, LLC Expansión in vitro de células postparto usando microportadores

Also Published As

Publication number Publication date
MX2010003511A (es) 2010-09-10
JP2010539970A (ja) 2010-12-24
JP5785394B2 (ja) 2015-09-30
AU2008306442B2 (en) 2014-12-04
EP2203555A2 (en) 2010-07-07
ES2582369T3 (es) 2016-09-12
EA201000425A1 (ru) 2010-10-29
KR20100087705A (ko) 2010-08-05
IL204788A (en) 2013-07-31
EP2203555B1 (en) 2016-04-13
US20100216237A1 (en) 2010-08-26
CN101868536B (zh) 2015-03-25
PT103843A (pt) 2008-01-09
PT103843B (pt) 2008-08-12
CA2701907A1 (en) 2009-04-09
US9546353B2 (en) 2017-01-17
WO2009044379A2 (en) 2009-04-09
EA025532B1 (ru) 2017-01-30
WO2009044379A3 (en) 2009-05-22
CN101868536A (zh) 2010-10-20
IL204788A0 (en) 2010-12-30
AU2008306442A1 (en) 2009-04-09
BRPI0817522A2 (pt) 2014-10-14

Similar Documents

Publication Publication Date Title
IL204788A0 (en) Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord
EP2512369B8 (en) Graft devices and methods of use
PT2379087E (pt) Células derivadas do tecido do cordão umbilical para o tratamento da dor neuropática e espasticidade
EP2510663A4 (en) METHOD AND ARRANGEMENT FOR MEDIA PLAYING
EP2640287A4 (en) Tissue removal device and method of use
EP2385798A4 (en) Apparatus and methods for tissue closure
IL201991A (en) Processed fish that includes frozen fish and fish stock from the same fish secret, and a method for making it
ZA201200882B (en) Medical supplies and method of producing the same
EP2039756A4 (en) CELL OR TISSUE CULTIVATION DEVICE AND CULTIVATION PROCESS
IL222729A (en) Tissue and device digestion method
ZA200906478B (en) Dominant gene suppression transgenes and methods of using same
EP2388314A4 (en) METHOD FOR CONTROLLING THE PROLIFERATION OF HEMATOPOIETIC NAIL CORD STEM CELLS AND APPLYING THEREOF
EP2405593A4 (en) METHOD AND DEVICE FOR PERFORMANCE COORDINATION OF MULTIPLE SUPPORTS
HUE038434T2 (hu) Biokatalizátorok és módszerek (S)-3(1-aminoetil)-fenol szintéziséhez
EP2427104A4 (en) METHOD AND SYSTEM FOR MONITORING OXYGENATION RATES OF LOGES AND FABRICS
EP2160465A4 (en) TUMOR GROWTH-INHIBITING CONNECTIONS AND METHOD FOR THEIR USE
IL213629A0 (en) Apparatus and method for the preservation of pancreatic tissue and islet cells for transplantation
EP2632351A4 (en) Percutaneous tissue grasping apparatus and method
EP2319808B8 (de) Verfahren und Reaktor zur Behandlung von Wasser
EP2282748A4 (en) TREATMENT OF BRAIN DAMAGES WITH NAIL CORD BLOOD CELLS
EP2496002A4 (en) Access method and equipment
EP2509711A4 (en) Continuous processing reactors and methods of using same
EP2145952A4 (en) PROCESS FOR THE REMOVAL OF BIOLOGICAL TISSUE
EP2531124A4 (en) Method and devices for the treatment of skin lesions
EP2145951A4 (en) PROCESS FOR THE REMOVAL OF BIOLOGICAL TISSUE